Cole Fiedler
Papers
2
Total Citations
6
H-Index
2
About
Cole Fiedler is a clinical researcher focused on refining perioperative risk assessment and outcomes in thoracic surgery, particularly for lung cancer patients undergoing robotic-assisted pulmonary lobectomy. His work centers on identifying preoperative biomarkers and physiological parameters that can predict surgical complications and recovery trajectories. Fiedler’s most cited study, “Effects of preoperative pulmonary function on perioperative outcomes after robotic-assisted pulmonary lobectomy” (2023, 4 citations), demonstrates his commitment to understanding how baseline lung health influences surgical success. In a complementary investigation, he critically evaluated the blood urea nitrogen to serum albumin ratio (BAR)—an emerging prognostic marker—as a predictor of adverse outcomes following robotic lobectomy. His findings, published in 2023 (2 citations), suggest that a high BAR does not significantly correlate with worse postoperative results, challenging assumptions about its utility in this specific surgical context. By systematically testing and refuting potential risk factors, Fiedler contributes to evidence-based preoperative counseling and helps refine clinical decision-making. His research, though early in citation impact, addresses a pressing need for tailored risk stratification in minimally invasive thoracic oncology, offering practical insights for surgeons and patients alike.
Research Focus
Key Achievements
Top Papers
- 1
- 2